Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Synerfill Vivid Plus is an injectable skin booster and aesthetic dermatology product developed by Maxcore Global. The formulation is a complex blend of high-molecular-weight and low-molecular-weight hyaluronic acid (HA), polydeoxyribonucleotide (PDRN), polynucleotide (PN), nicotinamide adenine dinucleotide (NAD), glutathione, and recombinant human (RH) collagen. It is designed for facial and body rejuvenation, aiming to improve skin hydration, elasticity, and cellular repair. PDRN and PN components are thought to stimulate tissue regeneration through adenosine receptor activation, while HA provides immediate volume and hydration. Glutathione and NAD provide antioxidant support and cellular energy. The product is manufactured in South Korea and marketed for professional use in aesthetic clinics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Synerfill Vivid Plus.